Dianthus Therapeutics, Inc. (DNTH)
50.75
+4.17
(+8.95%)
USD |
NASDAQ |
Feb 06, 16:00
50.71
-0.04
(-0.08%)
After-Hours: 20:00
Dianthus Therapeutics EPS Diluted (Quarterly) : -0.9728 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cartesian Therapeutics, Inc. | -1.381 |
| Royalty Pharma Plc | 0.6654 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.76M |
| Revenue (Quarterly) | 0.396M |
| Total Expenses (Quarterly) | 37.16M |
| Enterprise Value | 1.775B |
| Gross Profit Margin (Quarterly) | 75.00% |
| Profit Margin (Quarterly) | -9.28K% |
| Earnings Yield | -6.88% |
| Normalized Earnings Yield | -6.881 |